Figure 1.
(a) Erythematous plaque at the injection site 8 days following the second dose of the Pfizer–BioNTech vaccination. (b) Swelling is evident.
(a) Erythematous plaque at the injection site 8 days following the second dose of the Pfizer–BioNTech vaccination. (b) Swelling is evident.